Private Harbour Investment Management & Counsel, LLC Abb Vie Inc. Transaction History

Private Harbour Investment Management & Counsel, LLC

$92.3 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $375,286 - $441,693	-4,865 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $16,348 - $20,162	-210 Reduced 4.14%	4,865 $449,000
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $582,004 - $647,006	-6,546 Reduced 56.33%	5,075 $480,000
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $143,648 - $169,968	-1,600 Reduced 12.1%	11,621 $1.08 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $41,864 - $56,060	-455 Reduced 3.33%	13,221 $1.25 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $71,200 - $78,076	-795 Reduced 5.49%	13,676 $1.32 Million
Q3 2017 Nov 06, 2017	SELL	$69.85 - $89.22 $1.2 Million - $1.53 Million	-17,138 Reduced 54.22%	14,471 $1.29 Million
Q2 2017 Aug 08, 2017	BUY	N/A	31,609	31,609 $2.29 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Harbour Investment Management & Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Harbour Investment Management & Counsel, LLC with notifications on news.

Account